APA

Balestreri R., Bertolini S., Barban G., Montanari D., Jacopino J. E., Chiodini G. & Reggiani E. (19811025). [Effect of bis-(isobutyryloxy-2-ethyl)-1-N-(amino-4-methyl-2-pyrimidyl-5) methyl formamido-2-propene-1-yl disulfide (Sulbutiamin) in neurasthenic and neuroastheniform syndromes]. : Archivio "E. Maragliano" di patologia e clinica.

Chicago

Balestreri R, Bertolini S, Barban G, Montanari D, Jacopino J E, Chiodini G and Reggiani E. 19811025. [Effect of bis-(isobutyryloxy-2-ethyl)-1-N-(amino-4-methyl-2-pyrimidyl-5) methyl formamido-2-propene-1-yl disulfide (Sulbutiamin) in neurasthenic and neuroastheniform syndromes]. : Archivio "E. Maragliano" di patologia e clinica.

Harvard

Balestreri R., Bertolini S., Barban G., Montanari D., Jacopino J. E., Chiodini G. and Reggiani E. (19811025). [Effect of bis-(isobutyryloxy-2-ethyl)-1-N-(amino-4-methyl-2-pyrimidyl-5) methyl formamido-2-propene-1-yl disulfide (Sulbutiamin) in neurasthenic and neuroastheniform syndromes]. : Archivio "E. Maragliano" di patologia e clinica.

MLA

Balestreri R, Bertolini S, Barban G, Montanari D, Jacopino J E, Chiodini G and Reggiani E. [Effect of bis-(isobutyryloxy-2-ethyl)-1-N-(amino-4-methyl-2-pyrimidyl-5) methyl formamido-2-propene-1-yl disulfide (Sulbutiamin) in neurasthenic and neuroastheniform syndromes]. : Archivio "E. Maragliano" di patologia e clinica. 19811025.